Retroviral vectors for gene therapy.
Patrick Maier1, Christof von Kalle, Stephanie Laufs
1Department of Radiation Oncology, University Medical Centre Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
Future Microbiology
|November 16, 2010
Summary
Retroviral vectors have advanced gene therapy, successfully treating inherited diseases like immunodeficiencies. New lentiviral vectors offer improved safety, enabling treatment for more complex conditions.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Retroviral vectors, including gammaretroviral and lentiviral types, have been utilized in over 350 gene therapy studies in the past two decades.
- These vectors are favored for gene correction due to their capacity for stable, long-term transgene expression and ease of cloning and production.
Purpose of the Study:
- To review the advancements and applications of retroviral vectors in gene therapy.
- To highlight the development of safer lentiviral vectors and their potential for treating a wider range of diseases.
Main Methods:
- Review of clinical trial data and research publications on retroviral vector applications.
- Analysis of insertional mutagenesis events and their impact on vector design.
- Evaluation of safety profiles of new-generation lentiviral vectors.
Main Results:
- Successful treatment of several monogenic inherited diseases, particularly immunodeficiencies, using retroviral vectors.
- Identification of insertional mutagenesis risks, leading to the development of safer lentiviral vectors.
- Demonstration of long-term transgene expression and stable gene correction.
Conclusions:
- Retroviral vectors have a proven track record in gene therapy, with significant success in treating specific genetic disorders.
- Advances in lentiviral vector technology have enhanced safety and expanded the potential applications of gene therapy.
- Future generations of retroviral vectors are poised to treat a greater number of patients and more complex genetic diseases.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
02:33Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...